After more than three decades at Neurocrine, CEO Kevin Gorman will retire later this year, handing the reins of the $13 billion neuroscience drugmaker over …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Health care providers are in an acute financial situation. Record-high wages required to attract and retain talent coupled with price inflation not seen since the
“We have no indication that [Slayman’s death] was the result of his recent transplant,” Mass. General said in the statement. Slayman, who lived in Weymouth
The exposure to fine particulate matter (PM) in reinforced concrete production.